Literature DB >> 17943448

Neuropsychological and behavioral effects of antiepilepsy drugs.

David W Loring1, Susan Marino, Kimford J Meador.   

Abstract

Antiepilepsy drugs work by decreasing neuronal irritability, which may also result in the non-desired side effect of decreased neuropsychological function. In addition to cognitive side effects, antiepilepsy drugs (AEDs) may be associated with behavioral effects which may range from irritability and hyperactivity to positive psychotropic effects on mood. There have been many new medications released since the 1990s, and although they tend to have more favorable side effect profiles compared to their older counterparts, there continues to be a risk of decreased cognitive function with the majority of these agents. The effects of in utero antiepilepsy drug exposure are increasingly being investigated, and differential drug risk is beginning to be described for both anatomic and cognitive outcomes. Patients with epilepsy undergoing neuropsychological evaluations are commonly on AEDs, and it is important for the clinician to recognize the potential contribution of AED therapy to neuropsychological profiles. The present article serves to provide an overview of our current understanding regarding the risks of antiepilepsy drug use for both cognitive and behavioral side effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943448     DOI: 10.1007/s11065-007-9043-9

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  112 in total

1.  Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.

Authors:  D Blum; K Meador; V Biton; T Fakhoury; B Shneker; S Chung; K Mills; A Hammer; J Isojärvi
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

2.  Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy.

Authors:  C B Dodrill; J L Arnett; K W Sommerville; N M Sussman
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

3.  Effectiveness of first antiepileptic drug.

Authors:  P Kwan; M J Brodie
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

4.  Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal.

Authors:  Y Chen; J Chi Chow; I Lee
Journal:  Epilepsy Res       Date:  2001-04       Impact factor: 3.045

5.  Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.

Authors:  N Fritz; S Glogau; J Hoffmann; M Rademacher; C E Elger; C Helmstaedter
Journal:  Epilepsy Behav       Date:  2005-05       Impact factor: 2.937

6.  Late cognitive effects of early treatment with phenobarbital.

Authors:  S Sulzbacher; J R Farwell; N Temkin; A S Lu; D G Hirtz
Journal:  Clin Pediatr (Phila)       Date:  1999-07       Impact factor: 1.168

7.  In utero exposure to phenobarbital and intelligence deficits in adult men.

Authors:  J M Reinisch; S A Sanders; E L Mortensen; D B Rubin
Journal:  JAMA       Date:  1995-11-15       Impact factor: 56.272

Review 8.  Pregnancy in women who have epilepsy.

Authors:  Page B Pennell
Journal:  Neurol Clin       Date:  2004-11       Impact factor: 3.806

9.  Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

Authors:  A F Cohen; L Ashby; D Crowley; G Land; A W Peck; A A Miller
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.

Authors:  N Buchanan
Journal:  Seizure       Date:  1995-09       Impact factor: 3.184

View more
  42 in total

1.  Nontraditional epilepsy treatment approaches.

Authors:  Michael A Rogawski; Gregory L Holmes
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

2.  Growing up with epilepsy: a two-year investigation of cognitive development in children with new onset epilepsy.

Authors:  Bruce P Hermann; Jana E Jones; Raj Sheth; Monica Koehn; Tara Becker; Jason Fine; Chase A Allen; Michael Seidenberg
Journal:  Epilepsia       Date:  2008-09-10       Impact factor: 5.864

3.  Neuroanatomical correlates of cognitive phenotypes in temporal lobe epilepsy.

Authors:  Kevin Dabbs; Jana Jones; Michael Seidenberg; Bruce Hermann
Journal:  Epilepsy Behav       Date:  2009-06-26       Impact factor: 2.937

4.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

5.  Paying attention to school achievement in childhood absence epilepsy.

Authors:  David W Loring
Journal:  Epilepsy Curr       Date:  2014-03       Impact factor: 7.500

6.  Antiepileptic drug effects on subjective and objective cognition.

Authors:  Robert J Quon; Morgan T Mazanec; Samantha S Schmidt; Angeline S Andrew; Robert M Roth; Todd A MacKenzie; Martha Sajatovic; Tanya Spruill; Barbara C Jobst
Journal:  Epilepsy Behav       Date:  2020-01-29       Impact factor: 2.937

7.  Cognitive effects of antiepileptic drugs.

Authors:  Sung-Pa Park; Soon-Hak Kwon
Journal:  J Clin Neurol       Date:  2008-09-30       Impact factor: 3.077

8.  Increased EEG current-source density in the high Beta frequency band induced by levetiracetam adjunctive therapy in refractory partial epilepsy.

Authors:  Sung-Pa Park; Oh-Young Kwon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

9.  Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy.

Authors:  Ghaydaa A Shehata; Abd El-aziz M Bateh; Sherifa A Hamed; Tarek A Rageh; Yaser B Elsorogy
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

10.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.